IP Library › Granted Patent US 7,511,155
Granted Patent B2
US 7,511,155 · App. 10/519,433 · Granted Mar 31, 2009

Reagents and a method for saturation labelling of proteins

Assignee: GE Healthcare UK Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,511,155
App. No.
10/519,433
Granted
Mar 31, 2009
Kind
B2
Abstract

A matched set of fluorescent dyes is provided, wherein each dye of the set is capable of covalent attachment to a protein and wherein each of the dyes has a molecular structure and a charge that is matched one with the other, such that relative electrophoretic mobility of a protein labeled with one dye of the set is the same as the electrophoretic mobility of the protein labeled with a different dye of the set. The matched set comprises at least two different fluorescent dyes of formula: wherein n is 1, 2, or 3; Z 1 and Z 2 independently represent the carbon atoms necessary to complete a phenyl or naphthyl ring system; one of groups R 1 and R 2 is a target bonding group; remaining group R 1 or R 2 is selected from —(CH 2 ) 4 —W or —(CH 2 ) r —H; group R 3 is hydrogen, except when either R 1 or R 2 is —(CH 2 ) r —H, in which case R 3 is W; and W is selected from sulphonic acid and sulphonate. The invention also provides a method for saturation labeling of a protein with a fluorescent dye so as to label all available target amino acid, suitably cysteine, residues in the protein, thereby giving a single population of labeled protein molecules.

Claims (64)

1. A matched set of fluorescent dyes comprising two or more different fluorescent dyes of formula (I):

wherein n is different for each said dye and is 1, 2, or 3;

Z 1 and Z 2 independently represent the carbon atoms necessary to complete a phenyl or naphthyl ring system;

one of groups R 1 and R 2 is the group:

where Y is a target bonding group and in each dye of the set of dyes is the same and is selected from the group consisting of maleimido groups and iodoacetamido groups;

remaining group R 1 or R 2 is selected from —(CH 2 ) 4 —W or —(CH 2 ) r —H;

group R 3 is hydrogen, except when either R 1 or R 2 is —(CH 2 ) r —H, in which case R 3 is W;

W is selected from sulphonic acid and sulphonate;

p is an integer from 3 to 6;

q is 2 or 3; and

r is an integer from 1 to 5;

and salts thereof

and further wherein when n of two of said dyes differs by +1, one of p, q and r of said two dyes differs by −1.

2. A matched set of fluorescent dyes comprising at least two different fluorescent dyes of formula (II):

wherein n is different for each said dye and is 1, 2, or 3;

one of groups R 1 and R 2 is the group:

where Y is a target bonding group and in each dye of the set of dyes is the same and is selected from the group consisting of maleimido groups and iodoacetamido groups;

remaining group R 1 or R 2 is selected from —(CH 2 ) 4 —W or —(CH 2 ) r —H;

group R 3 is hydrogen, except when either R 1 or R 2 is —(CH 2 ) r —H, in which case R 3 is W;

W is selected from sulphonic acid and sulphonate;

p is an integer from 3 to 6;

q is 2 or 3; and

r is an integer from 1 to 5;

and salts thereof;

and further wherein when n of two of said dyes differs by +1, one of p, q and r of said two dyes differs by −1.

3. The matched set of dyes of claim 1 or claim 2 comprising at least two different fluorescent dyes wherein:

n is 1 or 2;

p is 4 or 5;

q is 2 or 3; and

r is 1, 2 or 3.

4. The matched set of dyes of claim 1 or claim 2 , wherein in each said dye Y is a maleimido group.

5. The matched set of dyes of claim 1 or claim 2 wherein said salts are selected from salts K + , Na + , NH 4 + , or containing (R) 3 NH + and (R) 4 N + wherein R is C 1 to C 4 alkyl.

6. A matched set of dyes selected from the group consisting of:

Set 1

1-(6-{[2-(2,5-dioxo-2,5 -dihydro-1H-pyrrol-1-yl)ethyl]amino}-6-oxohexyl)-2-[(1E,3E)-3-(1-ethyl-3,3-dimethyl-5-sulpho-1,3-dihydro-2H-indol-2-ylidene)prop-1-enyl]-3,3-dimethyl-3H-indolium (Compound I); and

1-(6-{[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl]amino}-6-oxohexyl)-3,3-dimethyl-2-[(1E,3E,5E)-5-(1,3,3-trimethyl-5-sulpho-1,3-dihydro-2H-indol-2-ylidene)penta-1,3-dienyl]-3H-indolium (Compound II);

Set 2

1-(6-{[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl]amino}-6-oxohexyl)-2-[(1E,3E)-3-(1-propyl-3,3-dimethyl-5-sulpho-1,3-dihydro-2H-indol-2-ylidene)prop-1-enyl]-3,3-dimethyl-3H-indolium (Compound III); and

1-(6-{[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl]amino}-6-oxohexyl)-3,3-dimethyl-2-[(1E,3E,5E)-5-(1-ethyl-3,3-trimethyl-5-sulpho-1,3-dihydro-2H-indol-2-ylidene)penta-1,3-dienyl]-3H-indolium (Compound IV);

Set 3

1-(6-{[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl]amino}-6-oxohexyl)-2-[(1E,3E)-3-(1-ethyl-3,3-dimethyl-5-sulpho-1,3-dihydro-2H-indol-2-ylidene)prop-1-enyl]-3,3-dimethyl-3H-indolium (Compound I); and

1-(5-{[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl]amino}-6-oxopentyl)-3,3-dimethyl-2-[(1E,3E,5E)-5-(1-ethyl-3,3-trimethyl-5-sulpho-1,3-dihydro-2H-indol-2-ylidene)penta-1,3-dienyl]-3H-indolium (Compound V);

Set 4

1-(6-{[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl]amino}-6-oxohexyl)-2-[(1E,3E)-3-(3,3-dimethyl(1-sulpho-butyl)-1,3-dihydro-2H-indol-2-ylidene)prop-1-enyl]-3,3-dimethyl-3H-indolium (Compound VI); and

1-(5-{[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl]amino}-6-oxopentyl)-3,3-dimethyl-2-[(1E,3E,5E)-5-(3,3-dimethyl-(1-sulpho-butyl)-1,3-dihydro-2H-indol-2-ylidene)penta-1,3-dienyl]-3H-indolium (Compound VII);

Set 5

1-(6-{[3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propyl]amino}-6-oxohexyl)-2-[(1E,3E)-3-(1-ethyl-3,3-dimethyl-5-sulpho-1,3-dihydro-2H-indol-2-ylidene)prop-1-enyl]-3,3-dimethyl-3H-indolium (Compound VIII); and

1-(6-{[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl]amino}-6-oxohexyl)-3,3-dimethyl-2-[( 1E,3E,5E)-5-(1-ethyl-3,3-trimethyl-5-sulpho-1,3-dihydro-2H-indol-2-ylidene)penta-1,3-dienyl]-3H-indolium (Compound IV); and

Set 6

1-(6-{[3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propyl]amino}-6-oxohexyl)-2-[(1E,3E)-3-(3,3-dimethyl(1-sulpho-butyl)-1,3-dihydro-2H-indol-2-ylidene)prop-1-enyl]-3,3-dimethyl-3H-indolium (Compound IX); and

1-(6-{[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl]amino}-6-oxohexyl)-3,3-dimethyl-2-[(1E,3E,5E)-5-(3,3-dimethyl-(1-sulpho-butyl)-1,3-dihydro-2H-indol-2-ylidene)penta-1,3-dienyl]-3H-indolium (Compound X).

7. A kit comprising a matched set of fluorescent dyes comprising at least two different fluorescent dyes having the formula (I):

wherein n is different for each said dye and is 1, 2, or 3;

Z 1 and Z 2 independently represent the carbon atoms necessary to complete a phenyl or naphthyl ring system;

one of groups R 1 and R 2 is the group:

where Y is a target bonding group and in each dye of the set of dyes is the same and is selected from the group consisting of maleimido groups and iodoacetamido groups;

remaining group R 1 or R 2 is selected from —(CH 2 )4—W or —(CH 2 ) r —H;

group R 3 is hydrogen, except when either R 1 or R 2 is —(CH 2 ) r —H, in which case R 3 is W;

W is selected from sulphonic acid and sulphonate;

p is an integer from 3 to 6;

q is 2 or 3; and

r is an integer from 1 to 5;

and salts thereof;

and further wherein when n of two of said dyes differs by +1, one of p, q and r of said two dyes differs by −1.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2020
From: GE HEALTHCARE EUROPE GMBH
To: GLOBAL LIFE SCIENCES SOLUTIONS GERMANY GMBH
Reel/Frame 053497/0121 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2020
From: GE HEALTHCARE UK LIMITED
To: GE HEALTHCARE EUROPE GMBH
Reel/Frame 053487/0672 →
CHANGE OF NAME Recorded Mar 18, 2006
From: BATESON; AMERSHAM LIFE SCIENCE; AMERSHAM LIFE SCIENCE LIMITED; AMERSHAM PHARMACIA BIOTECH UK LIMITED; AMERSHAM BIOSCIENCES UK LIMITED
To: GE HEALTHCARE UK LIMITED
Reel/Frame 017325/0248 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2005
From: WILLIAMS, KAREN; STONE, TIMOTHY; SIMMONDS, ADRIAN CHRISTOPHER; SWEET, ALISON CLAIRE; FOWLER, SUSAN JANET
To: AMERSHAM BIOSCIENCES UK LIMITED
Reel/Frame 016368/0841 →
Continuity (1)
Related Publication 20050233462A1 · Oct 20, 2005